Disc Medicine to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Disc Medicine (NASDAQ:IRON), a clinical-stage biopharmaceutical company specializing in hematologic disease treatments, has announced its participation in four major investor conferences in September 2025.

The company will engage in fireside chats at the Cantor Fitzgerald Global Healthcare Conference (Sept 3, 10:55 AM ET), Wells Fargo Healthcare Conference (Sept 4, 4:30 PM ET), H.C. Wainwright Global Investment Conference (Sept 9, 12:00 PM ET), and Morgan Stanley Global Healthcare Conference (Sept 10, 1:05 PM ET). All sessions will be accessible via webcast through Disc Medicine's investor relations website.

News Market Reaction

+0.28%

1 alert

+0.28% News Effect

On the day this news was published, IRON gained 0.28%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, announced today that company management will participate in fireside chats at four upcoming investor conferences:

• Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 3^rd at 10:55 a.m. ET.

• 2025 Wells Fargo Healthcare Conference on Thursday, September 4^th at 4:30 p.m. ET.

• H.C. Wainwright 27^th Annual Global Investment Conference on Tuesday, September 9^th at 12:00 p.m. ET.
  
• Morgan Stanley 23^rd Annual Global Healthcare Conference on Wednesday, September 10^th at 1:05 p.m. ET.
  

Live webcasts of the fireside chats will be available through the investor relations section of the Company's website at ir.discmedicine.com and an archived replay will be available after the event.

About Disc Medicine

Disc Medicine (NASDAQ:IRON) is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel treatments for patients who suffer from serious hematologic diseases. We are building a portfolio of innovative, potentially first-in-class therapeutic candidates that aim to address a wide spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, specifically heme biosynthesis and iron homeostasis. For more information, please visit www.discmedicine.com.

Media Contact

Peg Rusconi
Deerfield Group
peg.rusconi@deerfieldgroup.com

Investor Relations Contact

Christina Tartaglia
Precision AQ
christina.tartaglia@precisionaq.com

FAQ

When is Disc Medicine (IRON) presenting at the Cantor Fitzgerald Healthcare Conference 2025?

Disc Medicine will present at the Cantor Fitzgerald Global Healthcare Conference on Wednesday, September 3rd, 2025 at 10:55 AM ET.

How can investors access Disc Medicine's (IRON) conference presentations in September 2025?

Investors can access live webcasts of all fireside chats through the investor relations section of Disc Medicine's website at ir.discmedicine.com. Archived replays will be available after each event.

What is Disc Medicine's (IRON) main business focus?

Disc Medicine is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel treatments for patients with serious hematologic diseases.

Which investor conferences will Disc Medicine (IRON) attend in September 2025?

Disc Medicine will participate in four conferences: Cantor Fitzgerald Global Healthcare (Sept 3), Wells Fargo Healthcare (Sept 4), H.C. Wainwright Global Investment (Sept 9), and Morgan Stanley Global Healthcare (Sept 10).